findmyKOL
Clinical trialNCT00472355WithdrawnPhase 2Interventional

Low Dose Apomorphine and Parkinsonism

SponsorOregon Health and Science UniversityEnrollment0Parkinson's Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • John G. Nutt, MD

    Professor of Neurology, Oregon Health and Science University

    Principal Investigator
  • Steven Gunzler, MD

    Fellow and Clinical Instructor in Neurology, Oregon Health and Science University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Department of Neurology, Oregon Health and Science University, Mail Code Op32, 3181 Sw Sam Jackson Park Road

    Portland, Oregon, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2005
Primary completion
31 May 2007
Completion
31 May 2007
Last update posted
29 Nov 2018
Registered enrollment
0
Registry id
NCT00472355

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.